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Effective canine health surveillance systems can be used to monitor disease in the general population, prioritise
disorders for strategic control and focus clinical research, and to evaluate the success of these measures. The key
attributes for optimal data collection systems that support canine disease surveillance are representativeness of the
general population, validity of disorder data and sustainability. Limitations in these areas present as selection bias,
misclassification bias and discontinuation of the system respectively. Canine health data sources are reviewed to
identify their strengths and weaknesses for supporting effective canine health surveillance. Insurance data benefit
from large and well-defined denominator populations but are limited by selection bias relating to the clinical events
claimed and animals covered. Veterinary referral clinical data offer good reliability for diagnoses but are limited by
referral bias for the disorders and animals included. Primary-care practice data have the advantage of excellent
representation of the general dog population and recording at the point of care by veterinary professionals but
may encounter misclassification problems and technical difficulties related to management and analysis of large
datasets. Questionnaire surveys offer speed and low cost but may suffer from low response rates, poor data
validation, recall bias and ill-defined denominator population information. Canine health scheme data benefit from
well-characterised disorder and animal data but reflect selection bias during the voluntary submissions process.
Formal UK passive surveillance systems are limited by chronic under-reporting and selection bias. It is concluded that
active collection systems using secondary health data provide the optimal resource for canine health surveillance.
Keywords: Surveillance, Epidemiology, Canine, Data source, Primary-care practice, Referral practice, Insurance,
Questionnaire, Health scheme, Cancer registry, DisorderLay summary
An ability to identify at a population level how many
dogs, within breeds or across all breeds develop certain
diseases, either over a fixed time period (e.g. each year) or
as a proportion of the total population is very important.
This helps establish whether some animals and breeds are
particularly susceptible to a disease or whether conditions
are becoming more or less common. The percentage
of affected dogs in a population is called the disease
prevalence and the number of new cases of disease
in a year is called the disease incidence. These are
critical measurements for studying patterns of health and
disease and form a branch of medicine called epidemi-
ology. Veterinary epidemiology has been slow to develop
but is now recognised as being critical for improving ca-
nine health and welfare. To do this effectively, information* Correspondence: doneill@rvc.ac.uk
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unless otherwise stated.and health records about dogs, have to be collected. This
should be done in a standardised way where the same
terms are used to describe diseases and symptoms and
laboratory tests. The collection of disease information
is described as being health surveillance or disease
monitoring. To be effective, systems for doing this
should be representative of the whole population.
Methods for doing this are now developing but until
recently the only ways to collect such information
were by using records from pet insurance companies
or from veterinary referral clinics. Problems can exist
with such data as they can have a selection or refer-
ral bias and not truly represent the picture at the popula-
tion level or include information that is incorrect due to
disease misclassification. This review describes the his-
tory and development of health surveillance systems
in canine medicine and what their strengths and
weaknesses are. It also describes some of the new ways
this is now being taken forward to collect high quality
health data to support clinical and genetic studies.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Disease surveillance describes the monitoring of population
health to ascertain the existence and changes in disease
levels in combination with an appropriate mitigation plan
once disease levels become inordinate [1-3] and is now
an established veterinary activity for disease control [4].
Effective canine health surveillance provides information
that supports disorder prioritisation, improved disorder
management, focussed clinical research, advice on breed
standards reform and regulation to improve animal welfare
[5]. Optimal data sources for canine disease surveillance
require representativeness of the general population, a well-
defined denominator population, validity of disorder diag-
nosis data and sustainability. Limitations in these areas
present as selection bias, misclassification bias and discon-
tinuation of the system respectively [4].
Amongst other epidemiological applications, health
surveillance data can be analysed to derive disorder
prevalence proportion (proportion of animals affected)
and incidence risk (proportion of previously healthy
animals that become diseased over a specified period)
estimates, perform risk factor (attributes associated with
disease occurence) studies and examine survival in
affected dogs [1]. Prevalence data are currently available
on only 1% of inherited disorders affecting popular
UK dog breeds [6]. A deficiency of disorder prevalence
information relating to UK dogs has been identified as a
major constraint to effective reforms to purebred dog
health [7-9]. Novel epidemiological information on
disorders in dogs can assist with welfare prioritisation
of disorders for appropriate focus of research efforts
and breeding programs [6,10]. Increased awareness by
veterinarians of disorder frequency and survival can
improve diagnostic protocols, optimise case management
and enhance prognostic advice given to clients [11].
Collection processes for surveillance data may be
passive or active [4]. Passive collection occurs at the
discretion of the owner or veterinarian, whose willingness
or ability to participate can limit the validity of the emergent
data [12]. Passive systems typically suffer from incomplete
reporting, selection bias and frequently lack a defined
denominator population [13]. Active collection describes
systematic data collection methods, usually from a defined
population, location and timespan, and can be relatively
timely, complete and accurate [13].
Data used to support health surveillance may be primary
or secondary. Primary data are collected specifically for
the research while secondary data have been pre-collected
by a third party for some other reason. Primary data
collection offers better control of the types and quality
of the data and may be easier to validate. However,
secondary data sources may offer more efficient collection,
reduced costs, larger sample size, better representativeness
and reduced bias [14]. Secondary sources of health datafor dogs include pet insurance, referral practice and
primary-care practice records [14-16].
Surveillance data may be formatted as unstructured
(free-form text), semi-structured (non-standardised lists) or
structured data (standardised coding) [17]. Unstructured
data are problematic for large-scale studies because of
colloquial language, non-standard abbreviations and
misspellings [18,19] but may provide contextual informa-
tion that is otherwise unavailable [20]. Analytic methods
for free-form text are progressing [21]. Structured data
entry using standardised coding terminologies including
the VeNom codes [22] and the AAHA (American Animal
Hospital Association) Diagnostic Terms [23] may improve
analytic efficiency [24,25].
Obstacles to effective data collection, analysis and
interpretation are common to both human and animal
surveillance. These include ethical constraints [26], data
warehousing [27], setting valid case definitions [28], data
quality and missing data [29,30], appropriate coding sys-
tems [31], bias [32], generalisability [33], participation [34]
linking data sources [35], financial cost [36], clinical cod-
ing [37], developing syndromic surveillance [38] and im-
pact assessment [39]. Veterinary surveillance methods can
benefit from experiences gained during the development of
human methods [40]. Further opportunities for improved
veterinary surveillance methods stem from the advent of
Big Data techniques for data management, analysis and
accessibility [41], and developments in the science of
natural language processing (NLP) [42,43].
Diverse data sources have been used to support canine
disorder surveillance but there is an absence of a
universally-accepted standard for ‘good practice’ in
veterinary surveillance methodology [44]. This review is
intended to evaluate current sources of canine health
data and to identify their strengths and weaknesses as
surveillance sources in order to assist with interpretation
of results from studies based on these data.
Review
Pet insurance databases
Animal insurance databases have been increasingly used for
epidemiological research since the 1970s [45]. A literature
review in 2009 of publications based on dog insurance data
identified 16 Swedish studies using Agria Insurance data
(http://www.agriavet.co.uk/) and three UK studies using
PetProtect Insurance data (http://www.petprotect.co.uk/)
[15]. About 20 pet insurance providers [46] insure an
estimated 34.0-40.3% of UK dogs [46,47]. In Sweden,
68.4% of dogs are insured, with 61.0% of these insured
dogs being covered by Agria Pet Insurance [48] alone [49].
Estimates suggest that just 4% of dogs in Canada [50]
and 0.3-3.0% of dogs in America [51,52] are insured.
For research purposes, insurance databases benefit
from holding information on both the numerator clinical
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populations of dogs [15]. Validation studies between
Agria Insurance demographic data and veterinary
clinical records showed high agreement for dog breed
(95%) and sex (99%), fair agreement for diagnosis (84%)
but only moderate agreement for year of birth (66%),
suggesting that insurance data are of adequate quality
for research purposes [25]. Location information within
insurance records allows spatial analysis of geographic
risk factors. Post-code data have been used to show
associations between the incidence of canine atopic
dermatitis and average annual rainfall levels, proximity
to a veterinary dermatologist, country sector and increased
human population [53].
Although technically easy to analyse [25] and their
large size lending statistical power to gain meaningful
results even for uncommon breeds [54,55], insurance
data have some important limitations. Diagnostic term
validity may vary between disorders depending on the
ease of clinical diagnosis, the veterinarian’s clinical
acumen and the veterinary practice’s facilities. For example,
diagnosis validation for atopic dermatitis claims showed
high agreement with veterinary medical records that claim
dogs had allergic skin disease (97.6%) but only moderate
agreement for full atopic dermatitis diagnostic criteria
(40.9-84.2%) [15,56].
Insured dogs may poorly represent the wider national
dog population [15]. Insurance coverage varies with breed
and purebred status [49] and life-cover may end when dogs
reach 10 years of age [57]. Younger animals were heavily
overrepresented in a UK insured population [58], requiring
age-standardisation of results for generalisation [59].
Insured animals may receive more-frequent veterinary visits
and undergo more medical procedures than non-insured
animals [15]. A UK study using primary-care practice
electronic patient record (EPR) data showed that insured
dogs had over twice the odds of a diagnosis of chronic
kidney disease compared with uninsured dogs [11].
Insurance status may even affect mortality by impacting
on euthanasia decisions [15].
Insurance data include only clinical events that are
non-excluded and where the cost exceeds the deductible
excess. Exclusions have tended to increase over time and
vary by policy, breed and the medical history of individual
animals [15,60]. Insurance claim levels may also vary
between breeds. For example, death claims with an
associated diagnosis were received for just 50% of
insured crossbred dogs compared with over 80% of
insured Bernese Mountain Dogs and Cavalier King
Charles Spaniels [15]. Cohort insurance studies to
monitor health status within individual animals over time
can be problematic because repeat-disorder claim levels
are affected by changing insurance status and dynamic
exclusions applied over time based on claim history [61].Insurance data research has lead to many useful
publications on dogs covering specific disorders and
overall morbidity and mortality (Table 1). Good
understanding and interpretation of limiting factors
are important when considering insurance data for
canine health surveillance. Proposed studies should be
considered on an individual basis or possibly even
abandoned in the case of unavailable or inaccurate
data [15]. Swedish insurance studies have benefited
from an open approach to data sharing and strong research
collaboration between Agria Insurance and academic
colleagues that could be mirrored in other countries [55].
Referral practice clinical records
The Veterinary Medical Data Base (VMDB) holds 7 million
standardised abstracted records from 26 veterinary schools
in the US and Canada [75] with a coding system that
records diagnostic terms using either pathophysiologic,
histologic or descriptive terminologies [76]. VMDB data
mining is based on discrete factors including breed, age,
sex and diagnostic code and non-associated institutions are
charged for data searches.
The large study population lends high statistical power
to VMDB analyses, enabling exploration of rare disorders
or disorder-within-breed studies [12] such as thyroid
cancer, 0.2% prevalence [77], discospondylitis, 0.2%, [78],
bronchiectasis, 0.05%, [79] and leptospirosis, 0.04% [80].
Other prevalence studies that used VMDB data have
investigated cataract [81], glaucoma [81] and cardiac
tumours [82]. However, VMDB studies are limited by
inconsistencies in data completeness and quality, and by
the mixing of referral data with some primary-care data
[15]. Only nine of the contributing universities use the
structured SNOMED coding system that links clinical care
events to terms selected from a comprehensive list of
disorder concepts and descriptions [83,84]. The currency
of the VMDB data is low, given that just 14 universities
have uploaded data since the year 2000 [12,75].
Referral data spanning 1995–2010 from the University of
California-Davis Veterinary Medical Teaching Hospital
were analysed to report purebred dog predispositions to 24
inherited disorders [85]. The authors considered that more
intensive evaluation within breeds with published disorder
predisposition and increased willingness of owners of pure-
bred dogs to spend heavily on clinical investigations may
lead to over-representation of some disorders in specific
breeds and in purebreds more generally [86].
Despite the promise of good reliability for diagnoses from
referral clinical data, referral biases towards complicated
cases requiring more specialised care and towards locations
closer to specialist centres limit the generalisability of study
results [12]. Clients and animals that are referred are
filtered by diagnostic work-ups, insurance status and
financial considerations [15,87]. Referral bias is likely to
Table 1 Selected published and findings studies on dog health based on insurance data
Topic & main conclusion Insurer Country Reference
German Shepherd Dog, predisposed to immune-mediated diseases Agriaa Sweden Vilson et al. [62]
Atopic dermatitis, offspring of bitches fed non-commercial diet during lactation protected Agriaa Sweden Nodtvedt et al. (2007) [53]
Bone tumours, Irish Wolfhound, St. Bernard, and Leonberger at increased risk Agriaa Sweden Egenvall et al. (2007) [63]
Cancer, skin and soft tissue tumours had highest prevalence PetProtectb UK Dobson et al. (2002) [58]
Demography, insured dogs similar to the general dog population Agriaa Sweden Sallander (2001) [64]
Diabetes mellitus, highest incidence in Australian Terrier, Samoyed, Swedish Elkhound
and Swedish Lapphund
Agriaa Sweden Fall et al. (2007) [65]
Dystocia/caesarean section, Scottish terrier at increased risk Agriaa Sweden Bergstrom (2006) [66]
Heart disease, Irish Wolfhound, Cavalier King Charles Spaniel and Great Dane showed highest
mortality
Agriaa Sweden Egenvall et al. (2006) [67]
Intervertebral disc degeneration, Miniature Dachshund, Standard Dachshund and Doberman
Pinscher had highest incidence
Agriaa Sweden Bergknut et al. (2012) [68]
Lymphoma, Bull mastiff, Bulldog and Boxer had high incidence PetProtectb UK Edwards et al. (2003) [69]
Mammary tumours, highest incidence in English Springer Spaniel, Doberman and Boxer Agriaa Sweden Egenvall et al. (2005b) [70]
Morbidity and mortality, marked breed differences in survival Agriaa Sweden Bonnett and Egenvall (2010)
[55]
Morbidity and mortality (1995–1996), insurance data useful for epidemiological studies Agriaa Sweden Egenvall et al. (2000a) [60]
Mortality, wide breed differences in survival Agriaa Sweden Egenvall et al. (2000b) [71]
Mortality, >40% of deaths from trauma, tumours and locomotor disorders Agriaa Sweden Bonnett et al. (1997) [72]
Mortality (1995–2000), Irish Wolfhound and Great Dane had highest mortality Agriaa Sweden Egenvall et al. (2005a) [57]
Mortality (1995–2000), 62% of deaths from tumour, trauma, locomotor, heart and
neurological disorders
Agriaa Sweden Bonnett et al. (2005) [73]
Pyometra, increased risk Rough Collies, Rottweilers, Cavalier King Charles Spaniels, Golden
Retrievers, Bernese Mountain Dogs, and English Cocker Spaniels
Agriaa Sweden Egenvall et al. (2001) [74]
ahttp://www.agriavet.co.uk bhttp://www.petprotect.co.uk.
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of prevalence studies that compare multiple disorders
[12]. An ill-defined denominator population contain-
ing few healthy animals further limits referral data for
prevalence estimation [88]. Referral clinical datasets may
be less reliable for generalisable prevalence estimation and
may be best reserved to test hypotheses relating to specific
causal mechanisms [89].
Primary-care practice clinical records
Analysis of primary-care practice data benefits from the
cumulative clinical experience of general practitioners to
offer unique insights into companion animal health [24]
and can support an evidence-based approach that is
relevant to primary-care practitioners [90].
An early example of primary-care practice surveillance
(1998–2001) used manual paper-based data collection
by veterinary students undergoing extramural studies to
describe overall reasons for veterinary presentation and
the prevalence of dermatological diagnoses [91]. This
study concluded that, although practicable for short-term
and highly focused studies, clinical research using
paper-based records was highly labour-intensive and
unsustainable for long-term studies.Electronic recording of clinical data is now central to
human and animal healthcare [92,93]. Data collected
from the 90% of UK veterinary practices that use
electronic practice management systems (PMSs) can
contribute enormously to clinical research [94-96].
The ‘Independent Inquiry into Dog Breeding’ report
cited primary-care practice electronic clinical data
using standardised coding of diagnoses as the optimal data
source for reliable prevalence estimation [7]. However,
early attempts at large-scale electronic surveillance
struggled to cope with the large volumes of clinical
data collected [19] and initial veterinary PMSs did not en-
force structured coding systems [97], although there is
now evidence that practising veterinarians accept a clinical
rationale for standardised data recording [98,99].
In the US, the National Companion Animal Study
(NCAS) spanned 1992–1995 and analysed coded clinical
data from 31,484 dogs treated at 52 first-opinion clinics
[5]. Clinical diagnostic terms were recorded onto paper by
attending clinicians before codification to a standardised
nomenclature (PetTerms; developed dynamically during the
study) and electronic transfer to a proprietary PMS [100].
The first of three published NCAS studies described age,
breed, sex, diet and body condition score, and reported
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diagnosed [5]. However, the study was compromised
by limiting the denominator population to just those
animals with at least one coded diagnosis (36.3% of
unique animal records), potential transcription error
during the paper-to-electronic transfer of data and
the absence of a prior-standardised coding system.
Two further NCAS publications on obesity in cats
[101] and dogs [102] demonstrated the potential to
augment secondary EPR data with additional primary data
collection on diet and body condition score for enhanced
investigations [103]. The NCAS studies highlighted the
importance to sustainable surveillance of standardised
coding, direct recording of electronic data by clinicians,
inclusion of all clinical care events and electronic
integration between PMSs and research databases.
Eight hundred Banfield Pet Hospitals (http://www.
banfield.com/) have generated clinical data on over
2.2 million dogs across 43 states in the USA [104].
Surveillance based on Banfield clinical data benefits
from the use of a single PMS with daily uploads of
standardised EPRs to a single computer server [105].
Collaborative studies using Banfield Pet Hospital data
have reported on canine disorders including nematode
parasitism, demodicosis, pancreatitis and atopic dermatitis
(Table 2) while internal Banfield studies have been
published online as ‘State of Pet Health’ reports [104].
The National Companion Animal Surveillance Program
(NCASP) was developed at Purdue University in 2003 with
a $1.2 million grant from the Centers for Disease Control
and Prevention (CDC) to provide near real-time syndromic
surveillance of pet animals as sentinels for bioterrorism,
emerging zoonoses, toxic chemical exposures and for
veterinary drug and vaccine pharmacovigilance [116].
Banfield EPR data were linked with Antech DiagnosticsTable 2 Selected publications and findings on dog health bas
Topic
Gonadectomy, is a risk factor for obesity
Vaccine-associated adverse events, multiple vaccines doses administered per
Tick infestation, younger, male and sexually intact dogs at increased risk
Periodontal disease, associated with cardiovascular-related conditions
Periodontal disease, positive association with the incidence of azotaemic CKD
Nematode parasitism, age, body weight, sex, breed and geographic region w
Tick infestation, systematic monitoring of veterinary and human medical data
in tick activity
Pancreatitis, prevalence of 23 per 10,000 patients
Demodicosis, American Staffordshire Terrier, Staffordshire Bull Terrier and Chi
Atopic dermatitis, 1.7% prevalence
Castration, 64% prevalence
Environmental monitoring, methods using veterinary records require furtherelectronic laboratory reports from over 18,000 private
veterinary practices [117]. Resultant publications on dog
health have covered vaccine safety [19,107,118,119], tick
infestation [108] and toxic exposure [115]. However,
NCASP surveillance was limited by confidentiality issues,
delayed dissemination of results and difficulties in
managing such large volumes of data [117]. It is reported
that NCASP has been discontinued [120].
VetCompass (Veterinary Companion Animal Surveillance
System) was developed at the Royal Veterinary College
(RVC) in collaboration with the University of Sydney for
companion animal surveillance using primary-care practice
clinical data. A pilot phase, spanning 2007–2009, preceded
implementation of the full UK project from Septem-
ber 2009 onwards. VetCompass holds clinical data on
over 275,000 dogs from 189 UK practices (August
2013) (http://www.rvc.ac.uk/VetCompass/Index.cfm).
Attending clinicians record VeNom code [22] summary
diagnosis terms during episodes of clinical care [121].
Clinical data are automatically uploaded weekly to the
VetCompass database [122]. Published VetCompass
studies have covered pharmacotherapeutics [122],
demography [123] and specific disorders [11,121] of
dogs. Current VetCompass projects aim to prioritise
the welfare impact of common disorders in dogs, to
evaluate the longitudinal course of canine mitral valve
disease and to pilot the linkage of pedigree data to
clinical health records in collaboration with the UK
Kennel Club (KC) [47]. VetCompass has been developed
in Australia and preliminary project work is underway in
Spain, Germany and New Zealand. Realisation of the
full surveillance potential of VetCompass has been
constrained by limitations in automated information
extraction from large datasets but current work to apply
NLP methods offers promise [124].ed on Banfield Pet Hospital clinical data
Study period Reference
1998-2010 Lefebvre et al. [106]
visit increased risk 2002-2003 Moore et al. [107]
2002-2004 Raghavan et al. [108]
2002-2006 Glickman et al. [109]
2002-2008 Glickman et al. [110]
ere risk factors 2003-2006 Mohamed et al. [111]
can improve detection 2006-2007 Rhea et al. [103]
2006 Lewis [112]
nese Shar-pei at highest risk 2006 Plant et al. [105]
2007 Lund [113]
2007 Trevejo et al. [114]
development 2006 Maciejewski [115]
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(SAVSNET) was launched in 2008 at the University of
Liverpool as a pilot project collecting data from UK
veterinary diagnostic laboratories and veterinary practices
[125] before becoming a registered charity in 2012 and
entering a partnership with the British Small Animal
Veterinary Association (BSAVA) [126]. A SAVSNET
study of antibacterial prescribing patterns identified
the importance of data validation for automated search
strategies of primary-care practice data by showing
substantial variation between the positive predictive value
of four diagnoses, abscess (82%), diarrhoea (91%), cystitis
(100%) and coughing (90%) [127]. A moderate negative
impact from using opt-in consent was indicated by the
2.6% of clients who declined to participate [127],
suggesting the relevance of appropriate consent protocols
within project design [128]. Syndromic surveillance results
are also posted on the project website [129].
The Centre for Evidence-based Veterinary Medicine
(CEVM) was established in 2009 at the University of
Nottingham [130]. The CEVM aims to promote the use
of reliable and relevant science (or evidence) in clinical
decision-making between veterinary surgeons and the
owners of the animals. To facilitate this, the CEVM has
created a small network of sentinel practices who they
work very closely with, to look at the complexity of
consultations, the reliability and limitations of EPRs
and identify important areas for future research for
veterinarians, owners and their animals.
To-date, primary-care practice EPR data have been an
under-used surveillance resource [5]. Studies using EPR
data may encounter misclassification problems [127] and
technical difficulties related to management and analysis
of large datasets [120]. Additionally, primary-care veterinary
data mainly feature disorders that either prompted a
veterinary-care visit or were detected during an otherwise
veterinary examination and thus may miss that proportion
of the overall disorder burden of dogs that does not
receive veterinary attention. Just 44.1% of the true
illness events in dogs are severe or persistent enough
to lead to veterinary attention [131]. However, primary-
care EPR research boasts increasingly large datasets
for achieving good precision within study output
[132] and the investigation of rare events [133], good
prospects of generalisation to the wider dog popula-
tion from the 70% of UK dogs that are registered
with a veterinary practice [33,46] and clinical rele-
vance of the emergent results to practising veterinar-
ians [127]. Cohort data collection can facilitate survival
and co-morbidity analyses for chronic diseases [11,134].
Ongoing developments in database management, analytic
techniques, standardised coding and collaborative re-
search design should enhance the surveillance role for
primary-care practice EPR research [13].Veterinary cancer registries
Cancer registries systematically collect and analyse cancer
data and are considered key to human cancer control, with
449 registries covering 21% of the world human population
[135]. However, veterinary cancer registries are uncommon,
often short-lived and suffer from poor communication and
collaboration [136].
The VMDB began in 1964 as a hospital-based cancer
registry [75,137] and has published studies in dogs
that covered cutaneous mast cell tumours [138], pros-
tate carcinoma [139], cardiac tumours [82] and osteosar-
coma [140]. Referral bias limits generalisability from
VMDB study results to the wider dog population [12].
The Norwegian Canine Cancer Registry (NCCR) was
established in 1990 and has reported results from studies
that investigated mammary tumours in bitches [141,142].
The Danish Veterinary Cancer Registry (DVCR) was
established in 2005 as an online registry for passive
veterinarian upload of clinical information [137]. Published
DVCR studies have included cancer frequency in dogs in
Denmark [143] and canine mast cell tumours [144]. The
Animal Tumour Registry of Vicenza and Venice (Italy) was
established in 2005 and used data on 2,509 samples
submitted by 164 veterinary clinics to report cancer
incidence in dogs. A denominator dog population was
estimated using a telephone survey [145]. The Animal
Tumour Registry of Genoa (Italy) used data from
6,743 canine tumour biopsies submitted between 1985 and
2002 to report cancer incidence in dogs. A denominator
population was estimated using a capture-recapture
methodology [146]. These studies acknowledged limitation
from poor denominator population enumeration and
used differing methods to estimate missing values. The
telephone survey for population estimation benefitted
from relative speed and additional collection of other
useful demographic data.
Although useful for some risk factor studies, cancer
registry clinical data are limited for disease surveillance in
dogs by variable reporting, referral bias, denominator popu-
lation enumeration problems and geographical variation
[12,147]. While under-reporting might generally be ex-
pected, cancer registries may also over-report certain neo-
plasias because of screening programs, research focus, new
diagnostic modalities or free histopathology. Inconsistent
inclusion criteria, nomenclature and classification schemes
have limited comparisons of results across schemes. The
use of standardised coding and diagnostic systems, data ex-
traction directly from PMSs and cross-linking with path-
ology laboratory systems would enhance the application of
veterinary cancer registry data for disease surveillance.
Questionnaire-based data collection
Registered breeders represent a knowledgeable and
important sub-population of dog-owners. The KC/BSAVA
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from breeders on overall dog health, breeding and
mortality as well as puppy birth defects. Of approximately
56,363 questionnaires forwarded to breed club members,
13,759 useable forms were returned (24%), representing
36,006 live dogs [148]. This large survey provided a useful
resource of information on purebred dog health and
mortality but generalisation was limited by the low
response rate, absence of veterinary validation of reported
disorders and inclusion of only those dogs owned by breed
club members. Future studies aimed at breeder groups
could benefit from linkage to veterinary diagnoses and
greater prior involvement of breed clubs.
Information collected directly from the dog-owning
public may improve representativeness of the overall dog
population. The Pet Food Manufacturers Association
(PFMA) 2012 survey used data from 2,159 face-to-face
interviews to report demographic estimates for the UK dog
population [149]. However, the lack of reporting on
response rates, selection criteria, statistical weightings and
confidence intervals limit the validity of the PFMA survey
results. A UK general public telephone survey investigating
dog ownership achieved a response rate 37% from a total
of 1,656 calls and reported that 23.92% of households
owned at least one dog [46]. A random-digit dialling
telephone survey in Ireland generated 1,250 completed
responses from 105,803 calls (1.2%) to describe dog and
cat demography but was limited by the low completion
rate [150].
Veterinary practice questionnaires can collect data from
either the practice teams or their clients. A questionnaire
circulated by email and post to 2,763 UK veterinary prac-
tices was used to report the number of practice-registered
dogs but was limited by a low response rate (3.7%) [46]. A
questionnaire distributed at UK veterinary clinics and
dog shows investigating inter-dog aggression reported a
completion rate of 3,897 from 14,566 distributed ques-
tionnaires (26.8%) [151]. An Australian study distributed
questionnaires at veterinary clinics and pet shops to investi-
gate owners’ attitudes towards obesity in dogs and reported
a 36.5% response rate [152]. Integration of owner-recorded
data offers the potential to complement veterinarian-derived
data within broader study designs.
Questionnaire surveys are common methods for active
collection of primary veterinary epidemiological data
[153] and benefit from relative speed, repeatability, low
cost and the capture of information on multiple risk
factors and confounders. However, potential drawbacks
associated with the use of questionnaires include low
response rates, loss of information on temporality,
difficulties with data validation, recall and non-responder
bias, and ill-defined denominator populations [154].
Participation in questionnaire-based studies have been
declining by about 1% annually from 1970 to 2003 becauseof generally decreased volunteerism, over-surveying,
increasingly complicated surveys and conversion from
landline to mobile phone use [155]. That said, increasing
internet access has enhanced the promise for internet-based
questionnaires [156] and careful study design can
mitigate some of these drawbacks. Study designs that
include nested questionnaires can benefit from focused
primary data collection.
Canine health schemes
Over 120 dog breeds have at least one DNA test available
[157]. The results of formal DNA screening schemes
co-ordinated by the KC are published online, providing
surveillance data that can be linked with KC pedigree
information on phenotype and parentage [158]. These
data have been analysed to estimate the mutation
prevalence for primary lens luxation among affected breeds
[159]. However, selection bias arising from systematic
avoidance of or intensive testing of known affected lines
have limited generalisation from these studies to the wider
dog population [160].
Brain stem auditory evoked response (BAER) testing
distinguishes bilaterally and unilaterally hearing-impaired
dogs from non-affected animals [161]. BAER data have
been used to report prevalence estimates for deafness in
Dalmatians [162], Border Collies [163] and Australian
Cattle Dogs [164] as well as across multiple breeds [165].
These studies benefitted from well-defined case inclusion
criteria and large study sizes but the voluntary submission
process may have affected the presentation probabilities
for known deaf individuals.
The BVA (British Veterinary Association)/KC hip
dysplasia (HD) and elbow dysplasia (ED) schemes hold
data on over 100,000 radiographs assessed since 1984.
Dogs evaluated under these schemes must be permanently
identified by microchip or tattoo [166] and breed median
scores are published to assist breeding decisions [167].
Linkage between HD and ED schemes results and KC
pedigree data has allowed pedigree evaluation and
generation of estimated breeding values (EBVs) [168]
for HD [169] and ED [170] in Labrador Retrievers.
However, selection bias resulting from predominant
inclusion of registered purebreds and the unlikelihood
of submissions from dogs that are clinically affected or
have obviously affected radiographs limit generalisation
and may bias prevalence estimates downwards [171].
The BVA/KC/ISDS (International Sheepdog Society)
eye scheme holds eye test data spanning over 30 years of
testing for 11 hereditary eye conditions in over 50 breeds
[172]. These data have been analysed to estimate the
incidence [173] and inheritability [174] of multifocal
retinal dysplasia in the Golden Retriever and the incidence
of cataracts among Labrador Retrievers [175]. Eye scheme
data for research are limited by misclassification bias from
Table 3 Advantages and limitations to data sources used for health surveillance in dogs
Data source Advantages Limitations Applications
Pet insurance databases Large size Difficult to validate Agria Pet Insurance data analysis
in Sweden [15]
Defined denominator Questionable representativeness of the
general population
Pet Protect insurance data analysis
in UK [58,69]
High reliability for breed
and sex
Loss of data on low-cost or excluded
disorders
Coded diagnoses
Referral practice clinical records Good diagnostic reliability? Referral bias Veterinary Medical Data Base
(VMDB) [75]
Coded diagnoses? Poorly defined denominator
Large databases Poorly representative
Primary-care practice clinical records Large databases Diagnostic reliability? Banfield Pet Hospital [104]
Highly representative? Technical complexities NCAS [5]
Coded diagnoses Only events with veterinary care NCASP [116]
Defined denominator VetCompass [47]
Generalisability SAVSNET [129]
CEVM [130]
Veterinary cancer registries Human registries common Referral bias Veterinary Medical Data Base
(VMDB) [75]
Good diagnostic reliability Poorly defined denominator Danish Veterinary Cancer
Registry [137].
Poorly representative
Questionnaire-based data collection Relatively inexpensive Response rate The KC/BSAVA UK health survey of
purebred dogs [148].
Flexible Difficult to validate
Can nest within other
study designs
Loss of information on temporality
Canine health schemes Large databases Poorly representative BVA/KC hip dysplasia and elbow
dysplasia scheme [194]
Diagnostic reliability Selection bias BVA/KC elbow dysplasia
scheme [195]
Linkage to KC pedigree
data
The BVA/KC/ISDS eye scheme [172].
Permanent animal
identification
Other companion animal surveillance
systems in the UK
Relatively inexpensive Under-reporting SARSS [176]
Poorly defined denominator
Selection bias DACTARI [186]
Poor generalisability CICADA [189]
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bias from testing only a small proportion of KC-registered
purebreds and very few non-registered dogs [173].
Canine health schemes generally harvest primary
data from voluntary owner submissions and often
benefit from well-characterised data, permanent animal
identification (microchip, tattoo), openly published results
and linkage with genetic databases [166]. However,
intrinsic selection bias from passive collection processes
and questionable representation of the overall dog popula-
tion limit the generalisability of study results.Other companion animal surveillance systems in the UK
SARSS, Suspected Adverse Reaction Surveillance Scheme
Veterinary pharmacovigilance in the UK is monitored by
the Veterinary Medicines Directorate (VMD) via SARSS
using passive reporting of adverse events to veterinary
medicines in both animals and humans [176]. The number
of adverse events reported per year for dogs increased from
653 to 1,615 between the years 2003 to 2011 [177-185].
The 2011 result [182] equates to an average of only
one report per year for every 10 of the 17,260 registered
home-practising veterinary surgeons in the UK [95]. This
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with resultant questionable reliability of SARRS data for
general surveillance purposes.
DACTARI, The Dog and Cat Travel and Risk Information
The DACTARI surveillance scheme was launched in
2003 by the Department for Environment Food and
Rural Affairs with involvement from BVA and BSAVA as
a national voluntary reporting scheme to monitor exotic
diseases events in dogs and cats in Great Britain [186].
The scheme focuses on four disorders: leishmaniosis,
babesiosis, ehrlichiosis and dirofilariasis. However, from
2001 to 2011, only 109 reports were received for these four
diseases in dogs. Given that Bristol University reported 257
cases of canine leishmaniosis in the UK between 2005 and
2007 [187], this suggests heavy under-reporting to DAC-
TARI of the true exotic disease burden.
CICADA, The Companion Animal Disease Survey
The CICADA survey is coordinated by MSD Animal
Health (http://www.msd-animal-health.co.uk/) as a UK
web-based disease surveillance scheme with voluntary
online submissions of animal health data by veterinarians
and professional organisations. The scheme aims to report
disease trends, recent outbreaks and current hot spots
[188]. Between October 2011 and June 2012, only 93 insti-
tutions (laboratories, universities or veterinary practices)
submitted information to CICADA [189], suggesting high
selection bias and limited generalisability to the wider
animal population.
Rather than being useful for general surveillance,
passive reporting systems may better suited for generating
alarm signals that trigger more intensive targeted
surveillance [19]. Passive collection may suffer from
chronic under-reporting, inadequately defined denominator
populations, selection bias and poor generalisation, and
such systems are difficult to sustain in the long-term [190].
Conclusions
Increasing demand for veterinary surveillance is constrained
by decreasing availability of human and financial resources
[191]. Credible canine health surveillance requires a reliable
data source with a well-defined denominator population,
evidence of representativeness and validity and appropriate
study design [4]. Active data collection is preferred for
veterinary surveillance because of reduced selection bias
and known selection probability for each epidemiological
unit that permit estimation of absolute, rather than relative,
risk values [2]. Secondary data are becoming increasingly
important for companion animal surveillance because of
their collection efficiency, reduced costs, larger sample size,
better representativeness and reduced bias [14]. Integration
between data sources can facilitate knowledge extraction
and interpretability within individual studies and underlinesthe epidemiological importance of permanent identification
of individual animals [192,193].
Many data sources have been recruited for canine
health surveillance, each with distinct prevailing advan-
tages and limitations (Table 3). Insurance data benefit
from large and well-defined denominator populations
but are limited by selection bias relating to the clinical
events claimed and animals covered. Veterinary referral
clinical data offer good reliability for diagnoses but are
limited by referral bias for the disorders and animals
referred. Primary-care practice EPR data benefit from
strong alignment with the general dog population and
veterinary validation but encounter technical difficulties
related to the management and analysis of large datasets.
Veterinary cancer registries offer good diagnostic reli-
ability but may have ill-defined denominator populations
and poor representativeness. Questionnaire surveys are
relatively inexpensive and collect primary data but suffer
from issues relating to validation and response rates. Canine
health scheme data benefit from well-characterised disorder
and animal data but are subject to selection bias from the
voluntary submission process. Formal UK passive surveil-
lance systems are limited by chronic under-reporting and
selection bias. It is concluded that active collection systems
using secondary health data currently provide the optimal
single resource for canine health surveillance and that
linking multiple data sources can substantially amplify
the research potential.
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